门诊放射科网络Lumexa（LMRI）定价区间中点，融资4.63亿美元，市值达18亿美元。该公司是一家全 国性的门诊诊断影像服务提供商，通过全资拥有的机构和与医疗系统的合资企业，在13个州运营着184 家中心。该公司提供一系列先进和常规的影像检查方式，涵盖磁共振成像（MRI）、计算机断层扫描 （CT）、正电子发射断层扫描（PET）、X光、超声波和乳腺X光检查。Lumexa由Charlotte Radiology和 投资者WCAS于2018年成立，最初名为US Radiology Specialists。该公司已完成20项收购，使其在分散 的市场中占据领先地位，但其杠杆率高达3.7倍（按备考债务/过去12个月EBITDA计算）。上周股价持 平。 建筑服务提供商Cardinal Infrastructure（CDNL）以发行价中点定价，筹集2.42亿美元，市值达7.69亿美 元。Cardinal为住宅、商业、工业、市政和州政府项目提供水、污水和雨水系统等公用设施安装服务， 以及场地平整、铺路和其他场地开发工作。该公司专注于美国东南部市场，主要业务集中在北卡罗来纳 州的夏洛特、罗利和格林斯伯勒地区。截至2024年1 ...

美国医疗用品巨头Medline近日积极筹备纳斯达克IPO，交易代号"MDLN.US"，有望成为2025年美股最大规模IPO。 据12月8日提交的SEC文件，Medline计划发行1.79亿股，定价区间26-30美元/股，预计募资最高53.7亿美元，目标估值达553亿美元。该公司创立于1910 年，是全球最大医疗用品制造商和分销商，产品涵盖手套、手术器械等医疗耗材。 2021年，Medline被黑石、凯雷及Hellman&Friedman三家私募以340亿美元收购私有化，去年12月决定重返资本市场。财务数据显示，2025年前九月 Medline净利9.77亿美元，营收206亿美元，均同比增长。但公司警告，对等关税将导致2025年税前净利减少3.25-3.75亿美元，2026年再减1.5-2亿美元。 市场预计，Medline将于12月17日正式挂牌交易。 ...

In this week’s edition of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics investments, Forbes’ inaugural top hospitals list, and more. To get it in your inbox, subscribe here.Charlie Mills, Medline’s former CEO and a key member of its founding familyAFP via Getty ImagesMedical supplies giant Medline’s IPO is set to be this winter’s blockbuster–worth up to $55 billion. Documents for it also reveal for the first time the remaining stake of the Mills family, who founded the company in 19 ...

Core Insights - Medline has filed for an IPO aiming to raise up to $5.37 billion, which would value the company at approximately $55 billion, making it one of the largest public listings in the US for 2025 [1][4] - The company plans to list 179 million shares on the Nasdaq Global Select Market with an expected price range of $26 to $30 per share [1] Company Overview - Medline employs around 43,000 people and reported net revenues exceeding $25 billion in 2024, with net sales of $20.6 billion for the nine months ending September 27, 2025 [2] - The total addressable market for Medline is estimated to be around $375 billion annually, with the US market representing $175 billion of this opportunity [2] Market Opportunity - The company anticipates long-term growth in the US market driven by factors such as an aging population and increasing prevalence of chronic conditions, which are expected to elevate health expenditures [3] - Medline aims to achieve net sales growth through international expansion and ongoing innovation initiatives [3] IPO Context - If successful, Medline's IPO would be the largest in the medtech and broader healthcare sector for 2025, contrasting with the trend of AI-driven medtech IPOs this year [4] - Other notable AI medtech IPOs in 2025 include Beta Bionics and Kestra, raising $204 million and $235 million respectively [5]

智通财经APP获悉，聚焦医疗耗材的美国大型医疗保健公司Medline Inc. 正寻求通过在美国股市进行首 次公开募股(IPO)最多筹集53.7亿美元资金，为史上规模最大的一批私募股权支持的上市交易之一奠定 基础，同时也将是今年筹资规模最大的美股IPO事项，甚至有可能2025年全球股市最大规模IPO。 根据该公司周一向美国证券交易委员会(SEC)提交的文件，这家总部位于美国伊利诺伊州诺斯菲尔德 (Northfield, Illinois)的医疗保健公司计划发行1.79亿股股票，发行价区间为每股26至30美元。该公司背后 股东包括全球私募巨头黑石集团(Blackstone Inc.)、凯雷集团(Carlyle Group Inc.)以及 Hellman & Friedman，并已从所谓的"基石投资者"群体获得大约23.5亿美元的认购承诺。 整体而言Medline是一家围绕"医疗耗材 + 供应链解决方案"的综合平台型供应商，通过自有工厂与庞大 的仓配网络，把数十万种耗材型的医疗产品送到各类医疗机构的一线使用场景。聚焦于为医院、诊所、 长期护理机构、手术中心、医生办公室、家庭护理机构以及零售渠道，研发、生产并分销各 ...

感恩节过后，美国IPO市场有望在未来两周迎来一波热潮，各家公司都急于抓住2025年的最后一个窗口 期，赶在假日淡季到来之前上市。 Medline的IPO有望成为今年最引人注目的上市之一，在市场进入2026年之际，它将成为衡量投资者情绪 的关键指标。 Medline是美国最大的医疗用品制造商和分销商之一，包括世界各地医院和养老院使用的外科和程序 包、手套和防护服。 来源：环球市场播报 美国医疗用品巨头Medline周一表示，计划通过首次公开募股（IPO）融资至多53.7亿美元，目标估值高 达553亿美元，预计这将是2025年美国规模最大的IPO。 该公司表示，计划在此次IPO中发行1.79亿股股票，预估价格区间为每股26-30美元。 ...

Private equity-backed Medline is aiming to raise as much as $5.37 billion in its initial public offering in the United States, the medical supplies provider said on Monday. ...

Group 1 - Three sizable IPOs and four SPACs debuted in the last week of October [2] - Navan, a corporate travel software provider, priced its IPO at the midpoint to raise $923 million [2]

Core Insights - Medline Inc. has filed to raise $100 million in an IPO but has the potential to raise up to $5 billion from the sale of its Class A common stock [1] Group 1: Company Overview - Medline Inc. is preparing for an IPO, indicating strong market interest and potential for significant capital raising [1] - The company is associated with Donovan Jones, an IPO research specialist with 15 years of experience in identifying high-quality IPO opportunities [1] Group 2: IPO Details - The IPO filing suggests a base target of $100 million, with a maximum potential of $5 billion, highlighting the company's growth prospects and investor interest [1] - IPO Edge, led by Donovan Jones, provides actionable information on growth stocks, including first-look IPO filings and a comprehensive IPO calendar [1]